Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenovaTSE:9341 -1.27%78 Graham Number is 円317.55 as of Mar. 2026. GuruFocus rates TSE:9341 with a GF Score™ of 78/100 and a GF Value™ of 円2,029.83 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 408 Medical Devices & Instruments companies, Genova ranks worse than 70.83% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-09-08), the stock price of Genova is 円620.00. Genova's graham number for the quarter that ended in Mar. 2026 was 円317.55. Therefore, Genova's Price to Graham Number ratio for today is 2.48.
The historical rank and industry rank for Genova's Graham Number or its related term are showing as below:
TSE:9341'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.16 Med: 1.71 Max: 2.8
Current: 2.76
During the past 6 years, the highest Price to Graham Number ratio of Genova was 2.80. The lowest was 1.16. And the median was 1.71.
TSE:9341's Price-to-Graham-Number is ranked worse than 70.83% of 408
companies
in the Medical Devices & Instruments industry
Industry Median: 1.79
vs TSE:9341: 2.76
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Genova's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Mar. 2026 )
=
620.00
/
249.77
=
2.48
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Genova Graham Number Related Terms
Genova Graham Number Historical Data
* Premium members only.
The historical data trend for Genova's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9341 vs ABT, SYK, MDT: Graham Number Comparison
For the Medical Devices subindustry, Genova's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genova Price-to-Graham-Number vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genova's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Genova's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genova (TSE:9341) has a Graham Number of 円317.55 as of Mar. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on Genova and its competitors. According to the industry distribution chart, Genova ranks #289 out of 408 companies in the Medical Devices & Instruments industry, placing it in the top 70.8%.
Is Genova's Graham Number too high?
Genova's current Graham Number is 円317.55. Based on the distribution chart, Genova ranks #289 out of 408 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Genova has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Genova's Graham Number compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genova ranks #289 out of 408 companies for Graham Number. This places Genova in the lower half of its industry. The industry median Graham Number is 1.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Medical Devices & Instruments company?
The median Graham Number among Medical Devices & Instruments companies is 1.79, based on 408 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Genova and its competitors. For the Medical Devices & Instruments industry, the median Graham Number is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genova's current Graham Number is 円317.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genova stock overvalued right now?
Based on GuruFocus' analysis, Genova (TSE:9341) is currently considered Possible Value Trap. The stock's GF Value™ is 円2,029.83, compared to a current price of 円620.00 — trading 69.5% below its estimated fair value. The current Graham Number is 円317.55. Genova's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Genova (TSE:9341), the current Graham Number is 円317.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genova (TSE:9341) Overvalued in 2026?
Based on GuruFocus' analysis, Genova stock appears to be undervalued.
The current stock price of 円620.00 is trading 69.5% below its estimated GF Value™ of 円2,029.83.
GuruFocus considers Genova to be Possible Value Trap.
Key valuation signals for TSE:9341:
Graham Number: 円317.55
GF Value™: 円2,029.83 vs. price of 円620.00 (69.5% below fair value)
No single metric tells the full story. See the TSE:9341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genova Inc manages operations of the medical information site and sales of automatic reception and payment machines for clinics. The group operates in two reportable segments: Medical Platform Business and the Smart Clinic Project. The majority of its revenue is generated from the Medical Platform Business, which operates an online media site (Medical Dock) that provides preventive information and health knowledge to users (patients) on diseases and symptoms. In addition, it also supports users in finding a family doctor that suits them. The Smart Clinic Business develops and provides services that improve the convenience and efficiency of non-medical procedures at medical institutions.
78GF Score
Get the complete analysis for TSE:9341
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9341 has been successfully added to your 
